Cargando…

Peptide Vaccines for Hypertension and Diabetes Mellitus

Vaccines are commonly used as a preventive medicine for infectious diseases worldwide; however, the trial for an amyloid beta vaccine against Alzheimer’s disease will open a new concept in vaccination. In case of therapeutic vaccines for cancer, their targets are usually specific antigens in cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakagami, Hironori, Koriyama, Hiroshi, Morishita, Ryuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494253/ https://www.ncbi.nlm.nih.gov/pubmed/26344893 http://dx.doi.org/10.3390/vaccines2040832

Ejemplares similares

Gene Therapy and Cell-Based Therapies for Therapeutic Angiogenesis in Peripheral Artery Disease
por: Shimamura, Munehisa, et al.
Publicado: (2013)

Development of an IL-17A DNA Vaccine to Treat Systemic Lupus Erythematosus in Mice
por: Koriyama, Hiroshi, et al.
Publicado: (2020)

AJP001, a novel helper T‐cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccine
por: Tenma, Akiko, et al.
Publicado: (2019)

Inhibition of Neointima Formation through DNA Vaccination for Apolipoprotein(a): A New Therapeutic Strategy for Lipoprotein(a)
por: Kyutoku, Mariko, et al.
Publicado: (2013)

Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice
por: Nakagami, Futoshi, et al.
Publicado: (2013)

A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction
por: Watanabe, Ryo, et al.
Publicado: (2017)

A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke
por: Kurinami, Hitomi, et al.
Publicado: (2016)

Development of novel DNA vaccine for VEGF in murine cancer model
por: Kyutoku, Mariko, et al.
Publicado: (2013)

Therapeutic vaccine for chronic diseases after the COVID-19 Era
por: Nakagami, Hironori, et al.
Publicado: (2021)

A novel angiotensin II peptide vaccine without an adjuvant in mice
por: Nakamaru, Ryo, et al.
Publicado: (2021)

Recent Progress in Therapeutic Angiogenesis
por: Nakagami, Hironori, et al.
Publicado: (2007)

Lymphedema and Therapeutic Lymphangiogenesis
por: Saito, Yukihiro, et al.
Publicado: (2013)

Brief report on a phase I/IIa study to assess the safety, tolerability, and immune response of AGMG0201 in patients with essential hypertension
por: Nakagami, Hironori, et al.
Publicado: (2021)

Peptide vaccine for semaphorin3E ameliorates systemic glucose intolerance in mice with dietary obesity
por: Yoshida, Yohko, et al.
Publicado: (2019)

Prevention of bleomycin-induced pulmonary fibrosis by a RANKL peptide in mice
por: Ju, Nan, et al.
Publicado: (2022)

RANKL system in vascular and valve calcification with aging
por: Kawakami, Ryo, et al.
Publicado: (2016)

Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis
por: Ju, Nan, et al.
Publicado: (2019)

Effect of prorenin peptide vaccine on the early phase of diabetic retinopathy in a murine model of type 2 diabetes
por: Yokota, Harumasa, et al.
Publicado: (2022)

Therapeutic Effects of Systemic Administration of the Novel RANKL-Modified Peptide, MHP1, for Ischemic Stroke in Mice
por: Shimamura, Munehisa, et al.
Publicado: (2018)

Novel Anti-Microbial Peptide SR-0379 Accelerates Wound Healing via the PI3 Kinase/Akt/mTOR Pathway
por: Tomioka, Hideki, et al.
Publicado: (2014)

Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19)
por: Nakagami, Hironori, et al.
Publicado: (2023)

Acquisition of Humoral Immune Responses in Convalescent Japanese People with SARS-CoV-2 (COVID-19) Infection in 2021
por: Monzen, Koshiro, et al.
Publicado: (2023)

Development of a novel RANKL-based peptide, microglial healing peptide1-AcN (MHP1-AcN), for treatment of ischemic stroke
por: Shimamura, Munehisa, et al.
Publicado: (2018)

Modification of a novel angiogenic peptide, AG30, for the development of novel therapeutic agents
por: Nakagami, Hironori, et al.
Publicado: (2012)

Peptide-based vaccine targeting IL17A attenuates experimental spondyloarthritis in HLA-B27 transgenic rats
por: Hayashi, Hiroki, et al.
Publicado: (2023)

The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice
por: Yoshida, Shota, et al.
Publicado: (2020)

Development of a novel antimicrobial peptide, AG-30, with angiogenic properties
por: Nishikawa, Tomoyuki, et al.
Publicado: (2009)

The kidney and hypertension in diabetes mellitus
Publicado: (1989)

Development of anti-thrombotic vaccine against human S100A9 in rhesus monkey
por: Shimamura, Munehisa, et al.
Publicado: (2021)

The Mechanism of White and Brown Adipocyte Differentiation
por: Nakagami, Hironori
Publicado: (2013)

Low alpha-synuclein levels in the blood are associated with insulin resistance
por: Rodriguez-Araujo, Gerardo, et al.
Publicado: (2015)

Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice
por: Kawakami, Ryo, et al.
Publicado: (2018)

Efficacy and safety in mice of repeated, lifelong administration of an ANGPTL3 vaccine
por: Fukami, Hirotaka, et al.
Publicado: (2023)

Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults
por: Nakagami, Hironori, et al.
Publicado: (2022)

C-Peptide as a Therapy for Type 1 Diabetes Mellitus
por: Washburn, Rachel L., et al.
Publicado: (2021)

Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
por: Fukami, Hirotaka, et al.
Publicado: (2021)

Advances in oral peptide drug nanoparticles for diabetes mellitus treatment
por: Li, Yan, et al.
Publicado: (2022)

Diabetes Mellitus and Hypertension in an African Population
por: Oli, J. M., et al.
Publicado: (1986)

A global view of hypertensive disorders and diabetes mellitus during pregnancy
por: Jiang, Li, et al.
Publicado: (2022)

Cardiac and Renal Protective Effects of Irbesartan via Peroxisome Proliferator‐Activated Receptorγ–Hepatocyte Growth Factor Pathway Independent of Angiotensin II Type 1a Receptor Blockade in Mouse Model of Salt‐Sensitive Hypertension
por: Kusunoki, Hiroshi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2okrjbq9jo5udivigjlkrpgbtm